Search results
Earnings call: 23andMe reviews strategic options amid revenue decline By Investing.com
Investing.com· 3 days ago23andMe Holding Co. (ME) disclosed a strategic review to enhance shareholder value and a potential...
23andMe stock soars nearly 10% after delivering top-line beat in Q4 By Investing.com
Investing.com· 3 days agoThe company's revenue of $64.0 million exceeded the analyst consensus of $55.82 million. Despite a...
A Running Mate’s History: $1 Billion, Cocaine, a Fling With Elon Musk
New York Times· 5 days agoNicole Shanahan, a lawyer who was married to Sergey Brin, a Google founder, led a rarefied and...
23andMe Holding Co (ME) Q4 2024 Earnings Call Transcript Highlig
Guru Focus· 3 days agoRevenue: $64 million for Q4, $220 million for the full year, representing a 31% and 27% decrease, respectively, over the same periods in the prior year.Gross P
The Kennedy Campaign’s Problems Are Piling Up
New York Magazine· 3 days agoIt’s too early to know if Robert F. Kennedy Jr.’s independent presidential candidacy will ultimately represent a small and forgettable vehicle for...
23andMe Fiscal Q4 Revenues Drop 31 Percent as Research Services, Genetic Test Kit Sales Shrink
GenomeWeb News· 3 days ago"A major component of our vision is to build a scalable preventive health service," 23andMe CEO Anne Wojcicki said in an after-market call with investors ...
Council Post: 4 Ways For Brands To Regain Relevance After Listening To Consumers
Forbes· 7 days agoThere are many reasons once-stellar brands begin to fail, and in my decades in the advertising...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 3 days agoSOUTH SAN FRANCISCO, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, reported its financial results for the fourth quarter and full year of fiscal year 2024 (
23andMe (ME) Q4 FY24 Earnings: Revenue Beats Estimates Despite 3
Guru Focus· 3 days agoRevenue: $64 million for Q4 FY24, exceeding analyst estimates of $55.82 million and down 31% year-over-year from $92.4 million.Annual Revenue: $219.6 million f